Actualités

The health care giant sent a torrent of cash to its owners, but the stock itself told a very different story about the last five years.

UnitedHealth Group (NYSE:UNH) carries the highest conviction among managed care names heading into the company’s July 16 earnings report, and the setup is doing the talking. Shares of UNH last traded around $430.72 on July 9, sitting on a more than 28% year-to-date gain and a more than 42% one-year return. The repricing thesis showed ... The Main Reason Behind Buying UnitedHealth Before July 16

UnitedHealth Group (UNH) is back in focus after raising earnings guidance, tightening cost controls and benefiting from higher Medicare Advantage plan rates, with investors watching closely ahead of the upcoming Q2 results. See our latest analysis for UnitedHealth Group. UnitedHealth Group’s share price has picked up momentum, with a 4.52% 1 month share price return and a 41.85% 3 month share price return. The 1 year total shareholder return of 47.99% reflects a strong recovery story that...

Earnings optimism, AI demand, and healthcare momentum drove gains.

Jim Cramer used his July 9, 2026 CNBC Stop Trading segment to plant a flag on managed care, framing CVS Health (NYSE:CVS) as the consolidation winner in a sector where insurers are finally getting paid for the risks they underwrite. RBC raised its price target on CVS Health, and Cramer connected that call to a ... Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”

The healthcare giant looks expensive at a glance, but a patient investor is effectively buying its future earnings at a significant discount.

The health insurer's stock price is up 61% since April.

The healthcare industry is growing, but UnitedHealth Group may not be the best healthcare investment around.

UnitedHealth plans to invest nearly $1.5B in AI for 2026, expanding automation, digital tools and software platforms to drive growth beyond traditional cost savings.

This company's recovery efforts are bearing fruit.

Google joining the Dow Jones just made the 30-stock index even stronger.

HouseCalls has been accused of generating trumped up diagnoses to hike UnitedHealth’s Medicare reimbursement. But the review found almost 97% of diagnoses found in the home visits were backed up by patients’ medical records, UnitedHealth said.

UnitedHealth Group (NYSE:UNH) has become the first major commercial insurer to cover Guardant Health's Shield blood test for early colorectal cancer screening. The new coverage applies to eligible adults aged 45 and older, expanding access to a blood-based alternative to traditional screening methods. For investors watching UnitedHealth Group, this coverage decision highlights how the insurer is using its scale to shape access to emerging screening tools. The stock last closed at $417.99,...

UnitedHealth Group (UNH) concluded the recent trading session at $417.99, signifying a -1.73% move from its prior day's close.

UnitedHealth is prioritizing profitability over rapid growth as improving margins, stronger earnings and Optum expansion aim to support a long-term turnaround.

Healthcare stocks are attractive in a choppy market. These funds, focusing on the broader sector, drugmakers, and biotechs, are worth a look.

Before the stock surged, management laid out a turnaround plan for its Aetna unit that was so explicit, they practically put a price tag on it.

CNC expands AI-driven fraud prevention and payment integrity to improve Medicaid margins, boost cost controls and support long-term earnings growth.

Stock Market Today: The Dow Jones index fell Monday, while tech futures rallied. Micron stock and Sandisk rebounded in premarket trading.

These three healthcare stocks provide stability, relatively high dividend yields, and consistent growth.

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.

UnitedHealth posted a higher net income margin last quarter, while both companies saw their revenue growth pause after a long expansion.

Guardant Health (GH) investors have a new number to think about this week. Bernstein SocGen Group raised its price target on the cancer-screening company's stock to $200 a share, up from $175. Bernstein also kept its Outperform rating intact. The new price target came less than a day after a ...

CVS Health Corporation (NYSE:CVS) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer showed a positive sentiment toward the stock, as he said: How about these outsized moves in the health insurers and the drug distributors? Oh, I like these. I bet […]

UnitedHealth has clawed its way back impressively from last year’s lows, and July 16 could be its biggest health check yet. Will another strong quarter keep the momentum rolling?

While Wall Street fixated on a gloomy forecast, the company was making a painful but telling choice that hinted at the turnaround to come.

UnitedHealth Group has delivered a 41.5% return over the past year, yet its valuation checks paint a more mixed picture, leaving investors weighing a strong share price run against what the broader metrics suggest about value. A 41.5% one-year return signals that expectations around UnitedHealth Group have already moved up meaningfully. Regulatory developments around pharmacy benefit management and expanded coverage decisions, such as new screening benefits, can support the long term...

Politicians serve on committees that set healthcare policy, monitor government contracts, and shape regulatory frameworks.

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including UnitedHealth (NYSE:UNH) and its peers.

Cigna's Evernorth launched AI-powered Pharmacy Forward to speed up specialty prescriptions, cut delays and boost efficiency with a $100M investment.